The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury
Abstract
UNLABELLED: In this prospective, controlled, randomized, single-center study, we investigated the safety of repetitive large-dose infusion of a novel hydroxyethyl starch solution (6% HES 130/0.4) in cranio-cerebral trauma patients. Patients were randomized to receive either HES 130/0.4 (n = 16) at repetitive doses of up to 70 mL x kg(-1) x d(-1) (which is the largest HES dose reported in the literature) or the control HES 200/0.5 (n = 15) up to its approved dose limit of 33 mL x kg(-1) x d(-1) followed by human albumin up to a total dose (HES 200/0.5 + albumin) of 70 mL x kg(-1) x d(-1). We found no differences between groups in mortality, renal function, bleeding complications, and use of blood products. There were also no major differences in coagulation variables. However, at some time points, factor VIII, von Willebrand factor, and ristocetin cofactor were higher in the HES 130/0.4 group despite the large HES doses administered. We conclude that HES 130/0.4 can safely be used in critically ill head trauma patients over several days at doses of up to 70 mL x kg(-1) x d(-1). IMPLICATIONS: There are concerns that infusion of certain hydroxyethyl starch (HES) types for plasma volume expansion may influence coagulation and renal function. We investigated the safety of the novel HES 130/0.4 in patients with severe cranio-cerebral trauma. The repetitive HES doses administered in this study are the largest reported in the literature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
THE ROLE OF SECONDARY BRAIN INJURY IN DETERMINING OUTCOME FROM SEVERE HEAD INJURY
Chesnut, R. M., Marshall, L. F., Klauber, M. R., Blunt, B. A., Baldwin, N., Eisenberg, H. M., Jane, J. A., Marmarou, A., & Foulkes, M. A. (1993) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199302000-00006 · Cited by 2,189
Wilkes, M. M., & Navickis, R. J. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-135-3-200108070-00007 · Cited by 486
Cited by
Hydroxyethyl Starches: Different Products – Different Effects
Westphal, M., James, M. F. M., Kozek-Langenecker, S., Stocker, R., Guidet, B., Van Aken, H., & Warner, M. A. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181a7ec82 · Cited by 383
Self-citationGuidet, B., Martinet, O., Boulain, T., Philippart, F., Poussel, J., Maizel, J., Forceville, X., Feissel, M., Hasselmann, M., Heininger, A., et al. (2012) · Critical Care · doi:10.1186/cc11358 · Cited by 344
Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function
Dart, A. B., Mutter, T. C., Ruth, C. A., & Taback, S. P. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007594.pub2 · Cited by 290
Effects of Hydroxyethyl Starch Solutions on Hemostasis
Kozek-Langenecker, S. A. (2005) · Anesthesiology · doi:10.1097/00000542-200509000-00031 · Cited by 287
Consensus statement of the ESICM task force on colloid volume therapy in critically ill patients
Reinhart, K., Perner, A., Sprung, C. L., Jaeschke, R., Schortgen, F., Johan Groeneveld, A. B., Beale, R., & Hartog, C. S. (2012) · Intensive Care Medicine · doi:10.1007/s00134-012-2472-9 · Cited by 282
Metadata
- Authors
- Neff, T. A., Doelberg, M., Jungheinrich, C., Sauerland, A., Spahn, D. R., & Stocker, R.
- Venue
- Anesthesia & Analgesia
- Published
- 2003-05
- Volume
- 96
- Issue
- 5
- Pages
- 1453-1459
- ISSN
- 0003-2999 (ISSN-L)
- OpenAlex
- W2005498036
- Cited by
- 179
- References
- 2
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury. https://app.cochat.ai/papers/10.1213/01.ane.0000061582.09963.fd
- The paper
- Neff, T. A., Doelberg, M., Jungheinrich, C., Sauerland, A., Spahn, D. R., & Stocker, R. (2003). Repetitive Large-Dose Infusion of the Novel Hydroxyethyl Starch 130/0.4 in Patients with Severe Head Injury. Anesthesia & Analgesia. https://doi.org/10.1213/01.ane.0000061582.09963.fd
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.